Sulaiman Kadhim, Panduranga Prashanth, Al-Zakwani Ibrahim
Department of Cardiology, Royal Hospital, Muscat-111, Oman.
J Saudi Heart Assoc. 2011 Jan;23(1):17-22. doi: 10.1016/j.jsha.2010.09.003. Epub 2010 Oct 7.
To assess gender-related differences in the presentation, management, and in-hospital outcomes among acute coronary syndrome (ACS) patients from Oman.
Data were analyzed from 1579 consecutive ACS patients from Oman during May 8, 2006 to June 6, 2006 and January 29, 2007 to June 29, 2007, as part of Gulf RACE (Registry of Acute Coronary Events). Analyses were conducted using univariate and multivariate statistical techniques.
In this study, 608 (39%) patients were women with mean age 62 ± 12 vs. 57 ± 13 years (p < 0.001). More women were seen in the older age groups (age <55 years: 25% vs. 43%, 55-74 years: 60% vs. 49% and >75 years: 15% vs. 8%; p < 0.001). Women had higher frequencies of diabetes, hypertension, hyperlipidemia, obesity, angina, and aspirin use, but less history of smoking. Women were significantly less likely to have ischemic chest pain, ST-elevation myocardial infarction (STEMI), non-STEMI and were more likely to have dyspnea, unstable angina, ST depression and left bundle branch block. Both groups received ACS medications and cardiac catheterization equally; however, women received anticoagulants (88% vs. 79%; p < 0.001), angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) (70% vs. 65%; p = 0.050) more and clopidogrel less (20% vs. 29%; p < 0.001). Women experienced more recurrent ischemia and heart failure but with similar in-hospital mortality (4.6% vs. 4.3%) even after adjusting for age (p = 0.500).
Women admitted with ACS were older than men, had more risk factors, presented differently with no difference in hospital mortality. This is similar to Gulf RACE study except for mortality. Women received anticoagulants/ACEIs /ARBs more but were under-treated with clopidogrel.
评估阿曼急性冠状动脉综合征(ACS)患者在临床表现、治疗及住院结局方面的性别差异。
作为海湾地区急性冠状动脉事件注册研究(Gulf RACE)的一部分,对2006年5月8日至2006年6月6日以及2007年1月29日至2007年6月29日期间来自阿曼的1579例连续性ACS患者的数据进行分析。采用单变量和多变量统计技术进行分析。
本研究中,608例(39%)患者为女性,平均年龄62±12岁,男性平均年龄57±13岁(p<0.001)。老年组中女性患者更多(年龄<55岁:25%对43%,55 - 74岁:60%对49%,>75岁:15%对8%;p<0.001)。女性患糖尿病、高血压、高脂血症、肥胖症、心绞痛以及使用阿司匹林的频率更高,但吸烟史较少。女性出现缺血性胸痛、ST段抬高型心肌梗死(STEMI)、非STEMI的可能性显著更低,而出现呼吸困难、不稳定型心绞痛、ST段压低和左束支传导阻滞的可能性更高。两组接受ACS药物治疗和心脏导管插入术的情况相同;然而,女性接受抗凝剂治疗的比例更高(88%对79%;p<0.001),接受血管紧张素转换酶抑制剂(ACEIs)或血管紧张素II受体阻滞剂(ARBs)治疗的比例更高(70%对65%;p = 0.050),接受氯吡格雷治疗的比例更低(20%对29%;p<0.001)。女性经历复发性缺血和心力衰竭的情况更多,但即使在调整年龄后,住院死亡率相似(4.6%对4.3%)(p = 0.500)。
因ACS入院的女性患者比男性年龄更大,危险因素更多,临床表现不同,但住院死亡率无差异。除死亡率外,这与海湾地区急性冠状动脉事件注册研究结果相似。女性接受抗凝剂/ACEIs/ARBs治疗的比例更高,但氯吡格雷治疗不足。